161 related articles for article (PubMed ID: 17609209)
1. Peptidomic identification and biological validation of neuroendocrine regulatory peptide-1 and -2.
Yamaguchi H; Sasaki K; Satomi Y; Shimbara T; Kageyama H; Mondal MS; Toshinai K; Date Y; González LJ; Shioda S; Takao T; Nakazato M; Minamino N
J Biol Chem; 2007 Sep; 282(36):26354-60. PubMed ID: 17609209
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine regulatory peptide-1 and -2: novel bioactive peptides processed from VGF.
Toshinai K; Nakazato M
Cell Mol Life Sci; 2009 Jun; 66(11-12):1939-45. PubMed ID: 19194657
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine regulatory peptide-1 and -2 (NERPs) inhibit the excitability of magnocellular neurosecretory cells in the hypothalamus.
Toshinai K; Saito T; Yamaguchi H; Sasaki K; Tsuchimochi W; Minamino N; Ueta Y; Nakazato M
Brain Res; 2014 May; 1563():52-60. PubMed ID: 24704271
[TBL] [Abstract][Full Text] [Related]
4. VGF peptides upon osmotic stimuli: changes in neuroendocrine regulatory peptides 1 and 2 in the hypothalamic-pituitary-axis and plasma.
D'Amato F; Cocco C; Noli B; Cabras T; Messana I; Ferri GL
J Chem Neuroanat; 2012 Jul; 44(2):57-65. PubMed ID: 22613228
[TBL] [Abstract][Full Text] [Related]
5. Distribution of neuroendocrine regulatory peptide-1 and -2, and proteolytic processing of their precursor VGF protein in the rat.
Mishiro-Sato E; Sasaki K; Matsuo T; Kageyama H; Yamaguchi H; Date Y; Matsubara M; Ishizu T; Yoshizawa-Kumagaye K; Satomi Y; Takao T; Shioda S; Nakazato M; Minamino N
J Neurochem; 2010 Aug; 114(4):1097-106. PubMed ID: 20524965
[TBL] [Abstract][Full Text] [Related]
6. Localization of neuroendocrine regulatory peptide-1 and-2 in human tissues.
Matsuo T; Yamaguchi H; Kageyama H; Sasaki K; Shioda S; Minamino N; Nakazato M
Regul Pept; 2010 Aug; 163(1-3):43-8. PubMed ID: 20471433
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization and biological function of neuroendocrine regulatory peptide-3 in the rat.
Fujihara H; Sasaki K; Mishiro-Sato E; Ohbuchi T; Dayanithi G; Yamasaki M; Ueta Y; Minamino N
Endocrinology; 2012 Mar; 153(3):1377-86. PubMed ID: 22253422
[TBL] [Abstract][Full Text] [Related]
8. Release of oxytocin and vasopressin by magnocellular nuclei in vitro: specific facilitatory effect of oxytocin on its own release.
Moos F; Freund-Mercier MJ; Guerné Y; Guerné JM; Stoeckel ME; Richard P
J Endocrinol; 1984 Jul; 102(1):63-72. PubMed ID: 6539805
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of glucagon-like peptide-1 (GLP-1) receptor, vasopressin, and oxytocin mRNAs in neurons of the rat hypothalamic supraoptic and paraventricular nuclei: effect of GLP-1(7-36)amide on vasopressin and oxytocin release.
Zueco JA; Esquifino AI; Chowen JA; Alvarez E; Castrillón PO; Blázquez E
J Neurochem; 1999 Jan; 72(1):10-6. PubMed ID: 9886049
[TBL] [Abstract][Full Text] [Related]
10. Oxytocin and vasopressin release within the supraoptic and paraventricular nuclei of pregnant, parturient and lactating rats: a microdialysis study.
Neumann I; Russell JA; Landgraf R
Neuroscience; 1993 Mar; 53(1):65-75. PubMed ID: 8469313
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine regulatory peptide-1 and neuroendocrine regulatory peptide-2 influence differentially feeding and penile erection in male rats: sites of action in the brain.
Melis MR; Sanna F; Succu S; Ferri GL; Argiolas A
Regul Pept; 2012 Aug; 177(1-3):46-52. PubMed ID: 22561139
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine regulatory peptide-2 regulates feeding behavior via the orexin system in the hypothalamus.
Toshinai K; Yamaguchi H; Kageyama H; Matsuo T; Koshinaka K; Sasaki K; Shioda S; Minamino N; Nakazato M
Am J Physiol Endocrinol Metab; 2010 Sep; 299(3):E394-401. PubMed ID: 20551287
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide endotoxin potentiates the effect of osmotic stimulation on vasopressin synthesis and secretion in the rat hypothalamus.
Grinevich V; Ma XM; Jirikowski G; Verbalis J; Aguilera G
J Neuroendocrinol; 2003 Feb; 15(2):141-9. PubMed ID: 12535156
[TBL] [Abstract][Full Text] [Related]
14. Chronic effects of neuroendocrine regulatory peptide (NERP-1 and -2) on insulin secretion and gene expression in pancreatic β-cells.
Kim JW; Rhee M; Park JH; Yamaguchi H; Sasaki K; Minamino N; Nakazato M; Song DK; Yoon KH
Biochem Biophys Res Commun; 2015 Feb; 457(2):148-53. PubMed ID: 25529453
[TBL] [Abstract][Full Text] [Related]
15. A physiological role for adrenomedullin in rats; a potent hypotensive peptide in the hypothalamo-neurohypophysial system.
Ueta Y; Serino R; Shibuya I; Kitamura K; Kangawa K; Russell JA; Yamashita H
Exp Physiol; 2000 Mar; 85 Spec No():163S-169S. PubMed ID: 10795919
[TBL] [Abstract][Full Text] [Related]
16. Neurokinin B receptor (NK3)-containing neurons in the paraventricular and supraoptic nuclei of the rat hypothalamus synthesize vasopressin and express Fos following intravenous injection of hypertonic saline.
Ding YQ; Lü BZ; Guan ZL; Wang DS; Xu JQ; Li JH
Neuroscience; 1999; 91(3):1077-85. PubMed ID: 10391485
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the central vasopressin and oxytocin axis after lesion of a brain osmotic sensory region.
Oliveira GR; Franci CR; Rodovalho GV; Franci JA; Morris M; Rocha MJ
Brain Res Bull; 2004 Jul; 63(6):515-20. PubMed ID: 15249117
[TBL] [Abstract][Full Text] [Related]
18. Expression of corticotropin releasing factor (CRF), urocortin and CRF type 1 receptors in hypothalamic-hypophyseal systems under osmotic stimulation.
Imaki T; Katsumata H; Miyata M; Naruse M; Imaki J; Minami S
J Neuroendocrinol; 2001 Apr; 13(4):328-38. PubMed ID: 11264720
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide mediates oxytocin secretion induced by osmotic stimulus.
Chriguer RS; Antunes-Rodrigues J; Franci CR
Brain Res Bull; 2003 Feb; 59(6):505-11. PubMed ID: 12576148
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin and oxytocin in stress.
Jezova D; Skultetyova I; Tokarev DI; Bakos P; Vigas M
Ann N Y Acad Sci; 1995 Dec; 771():192-203. PubMed ID: 8597399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
